Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted the survey from Feb. 24-26, 2026, among 1,189 U.S. adults, ages 45 and ...

The National Lung Screening Trial demonstrated a 20% relative reduction in lung cancer mortality with low-dose computed tomography screening, leading to implementation of lung cancer screening across ...

Districts could boost their ability to hire teachers who help students learn more and who stay on the job longer by improving their screening techniques, a newly released working paper concludes.

Social determinants of health (SDOH) screening tools have been prioritized in emerging healthcare delivery models aimed at transforming traditional care delivery and reimbursing a broader bench of ...

A committee of experts will conduct a study examining the current landscape of newborn screening (NBS) systems, processes, and research in the United States and consider sustainable adoption of ...